CarThera
Paris
About CarThera
CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since.The company’s proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reach the brain.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $79.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2023)
- Website: carthera.eu
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/carthera-7503 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.